Remove 2021 Remove Compounding Remove Immunization
article thumbnail

Pharmacist Involvement Helps Reduce Time to A1c Target

Drug Topics

of the United States population in 2021,” the authors wrote. “In Additional advantages include fewer emergency visits, hospitalizations, medication adherence, and associated cost savings. 2 “Prevalence of diabetes in the United States continues to rise, affecting an estimated 38.4 million people, or 11.6%

article thumbnail

FDA Approves Nitisinone for Treatment of Alkaptonuria

Drug Topics

Updated August 26, 2021. MedlinePlus. Alkaptonuria. Accessed June 19, 2025. Long-Term Study of Nitisinone to Treat Alkaptonuria. ClinicalTrials.gov identification: NCT00107783. Accessed June 19, 2025.

FDA 307
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Progress in Dermatology Paves the Way for Vaccine Development

Drug Topics

1 “In line with the goals of its Immunization Agenda 2030, WHO has identified a new list of 17 high-priority global endemic pathogens for vaccine research and development, of which skin pathogens account for at least 8, reinforcing the need for continued focus in this area.”

Vaccines 247
article thumbnail

Social Media Significantly Influences Attitudes, Behaviors Toward Skin Health

Drug Topics

billion people used social media in 2021, and this number is likely to grow to almost 6 billion in 2027. Social media was found to significantly impact the actions related to users’ skin health, according to a study published in the Journal of Medical Internet Research. According to the statistics, [over] 4.26 In April 2023, a total of 4.8

article thumbnail

GSK partners LifeMine on fungi-derived medicines

pharmaphorum

GlaxoSmithKline has thrown its financial and drug development weight behind LifeMine Therapeutics, a US startup that aims to find new therapeutics from fungi – widely regarded as an underexplored resource of biologically-active compounds. Image by jggrz from Pixabay .

article thumbnail

BMS in-licensed PKC theta inhibitor enters clinical trials

European Pharmaceutical Review

The compound is in development for immunology and inflammation indications. In May 2021, Bristol Myers Squibb and Exscientia expanded the collaboration in immunology & inflammation indications and oncology. The post BMS in-licensed PKC theta inhibitor enters clinical trials appeared first on European Pharmaceutical Review.

article thumbnail

7 health benefits of garlic

The Checkup by Singlecare

Garlic is loaded with organic sulfur compounds that make it particularly beneficial; these compounds fight inflammation, bacteria, fungi, and viruses, and have protective effects on the heart and kidneys. Stronger immune system Interested in another one of garlic’s many superpowers?